£3.5M
The pre-seed round was backed by RAW Ventures and Cedars-Sinai Ventures to fund clinical deployment and regulatory approvals.
"We’re focused on leveraging the unique capabilities of ultrasound and developing solutions to make it smarter, faster, and more reliable, with clinicians at the centre of that transformation. This trial will assess the effectiveness of FraiyaScan in real world conditions. Importantly, the frontline staff and patient feedback will help us to understand the acceptability of the technology, where time-pressured scans, staffing gaps, and service variability, that can affect outcomes, may also impact the performance and adoption of AI-based innovations."
F
Fraiya—London, UKRAW Ventures + 1 other